Renal autotransplantation (RA) has become a modality that may be used in complicated renovascular illnesses (renal artery aneurysms), severe ureteric injuries, chronic kidney discomfort, and traditionally unresectable renal tumors due to advancements in preservation and transplantation procedures. For this study, researchers provide the Oxford experience, the only UK-commissioned center doing RA for complicated renal cell malignancies, as well as a review of reported RA experience from other UK centers.

The facts and literature provided by the RA experience in the United Kingdom are primarily cased reports. Renovascular disease, ureteral pathology, and radiation prophylaxis are the most common reasons for doing RAs.

Renal autotransplantation is a possibility for a small number of individuals. It has comparable short- and long-term complication rates to other large surgeries. Extensive preoperative counseling in collaboration with diverse clinicians is critical for making informed decisions.